Market Exclusive

Majesco (NASDAQ:COOL) Files An 8-K Results of Operations and Financial Condition

Majesco (NASDAQ:COOL) Files An 8-K Results of Operations and Financial ConditionItem 2.02.

Results of Operations and Financial Condition.

On July 26, 2017, Majesco issued a press release announcing its financial results for the quarter ended June 30, 2017. A copy of the press release is attached hereto as Exhibit99.1, which is incorporated herein by reference.

The information furnished in this section of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release, dated July 26, 2017

[ on following page.]

Majesco ExhibitEX-99.1 2 v471543_ex99-1.htm EXHIBIT 99.1     Exhibit 99.1         PRESS RELEASE   Majesco Announces Fiscal 2018 First Quarter Financial Results   Q1 Fiscal 2018 revenue at $27.9 million,…To view the full exhibit click here
About Majesco (NASDAQ:COOL)
PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company’s PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions. Majesco (NASDAQ:COOL) Recent Trading Information
Majesco (NASDAQ:COOL) closed its last trading session down -1.02 at 20.51 with 34,501 shares trading hands.

Exit mobile version